+

AU2003211845A1 - ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION - Google Patents

ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION

Info

Publication number
AU2003211845A1
AU2003211845A1 AU2003211845A AU2003211845A AU2003211845A1 AU 2003211845 A1 AU2003211845 A1 AU 2003211845A1 AU 2003211845 A AU2003211845 A AU 2003211845A AU 2003211845 A AU2003211845 A AU 2003211845A AU 2003211845 A1 AU2003211845 A1 AU 2003211845A1
Authority
AU
Australia
Prior art keywords
anminoglycosides
lactamase
medicine
composition
environmental protection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003211845A
Other languages
English (en)
Inventor
Xiushu Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003211845A1 publication Critical patent/AU2003211845A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003211845A 2002-02-11 2003-02-08 ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION Abandoned AU2003211845A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB021050384A CN1191363C (zh) 2002-02-11 2002-02-11 β－内酰胺酶/氨基糖苷钝化酶融合基因其表达产物其组合物及其应用
PCT/CN2003/000119 WO2003068975A1 (fr) 2002-02-11 2003-02-08 GENES DE L'ENZYME MODIFIANT LA β-LACTAMASE/LES AMINOCLYCOSIDES, LEUR GENE DE FUSION, LEURS PRODUITS D'EXPRESSION, COMPOSITION LES CONTENANT ET LEURS UTILISATIONS EN MEDECINE ET DANS LA PROTECTION DE L'ENVIRONNEMENT

Publications (1)

Publication Number Publication Date
AU2003211845A1 true AU2003211845A1 (en) 2003-09-04

Family

ID=27672139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003211845A Abandoned AU2003211845A1 (en) 2002-02-11 2003-02-08 ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION

Country Status (3)

Country Link
CN (2) CN1191363C (fr)
AU (1) AU2003211845A1 (fr)
WO (1) WO2003068975A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1191363C (zh) * 2002-02-11 2005-03-02 陈秀枢 β－内酰胺酶/氨基糖苷钝化酶融合基因其表达产物其组合物及其应用
CN101003798B (zh) * 2006-01-17 2010-05-12 温州医学院 一种重组超广谱β-内酰胺酶的表达纯化及其高密度发酵方法
FI20086225L (fi) * 2008-12-22 2010-06-23 Tuula Heinonen Menetelmä ja tuotteet antibioottijäämien hajottamiseksi
FR3027307B1 (fr) * 2014-10-16 2016-11-04 Azurrx Sas Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant
CN108355141B (zh) * 2018-01-11 2019-06-18 广西壮族自治区人民医院 一种基于TIM-4-Fc融合蛋白的治疗变应性疾病的药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1707078A1 (ru) * 1989-11-21 1992-01-23 Институт биоорганической химии им.М.М.Шемякина Рекомбинантна плазмидна ДНК рТНУЗ14, кодирующа полипептид со свойствами тимозина @ человека, рекомбинантна плазмидна ДНК рТНУ12 - промежуточный продукт дл ее конструировани и штамм бактерий ЕSснеRIснIа coLI - продуцент полипептида со свойствами тимозина @ человека
EP0467049A1 (fr) * 1990-07-16 1992-01-22 American Cyanamid Company Séquences d'ADN et séquences d'amino-acides des enzymes classe B bêta-lactamase de bactéroides fragilis
FR2687410A1 (fr) * 1992-02-14 1993-08-20 Pasteur Institut Beta-lactamase recombinante, utilisable en tant que molecule porteuse pour la preparation de compositions immunogenes.
WO1994026913A2 (fr) * 1993-05-13 1994-11-24 Plant Genetic Systems, N.V. Gene marqueur
CN1191363C (zh) * 2002-02-11 2005-03-02 陈秀枢 β－内酰胺酶/氨基糖苷钝化酶融合基因其表达产物其组合物及其应用

Also Published As

Publication number Publication date
CN1438315A (zh) 2003-08-27
CN1296483C (zh) 2007-01-24
CN1191363C (zh) 2005-03-02
WO2003068975A1 (fr) 2003-08-21
CN1630726A (zh) 2005-06-22

Similar Documents

Publication Publication Date Title
WO2002046364A8 (fr) Genes associes au stress mecanique, produits d'expression de ces genes et utilisation de ces genes et de leurs produits d'expression
AU2003287324A1 (en) Gene expression systems and recombinant cell lines
IL233352A0 (en) RNA molecules and pharmaceutical preparations containing them and their uses
AU2002312933A1 (en) CDK inhibiting pyrimidines, production thereof and their use as medicaments
AU2001245619A1 (en) Human genes and gene expression products
AU2003259271A1 (en) Bipolar articles and related methods
AU2003284388A1 (en) Organellar targeting of rna and its use in the interruption of environmental gene flow
AU4053699A (en) Novel human genes and gene expression products
AU2003225644A1 (en) Wax ester synthase dna sequence, protein and uses thereof
AU2003233719A1 (en) Modifying the dna recombination potential in eukaryotes
AU2003241469A1 (en) Personal care articles with fragrance delivery system
AU2003233359A8 (en) Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
AU2002365188A1 (en) Nucleic acid delivery and expression
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2003211845A1 (en) ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION
AU3457899A (en) Blk genes, gene products and uses thereof in apoptosis
AU2003262744A1 (en) Alpha-AMYLASE ASSAY AND USES THEREOF
AU2003295824A1 (en) Cell adhesion and extracellular matrix proteins
AU2001264245A1 (en) Novel enzyme gene and its expression product
AU2001287269A1 (en) Human genes and expression products
AU2003276828A1 (en) Minicell display and products therefrom
AU2003265431A1 (en) Cell adhesion and extracellular matrix proteins
AU6424501A (en) Novel enzyme gene and its expression product
AU2003258772A1 (en) Novel neutracetical and pharmaceutical compositions and their uses
AU2003228872A1 (en) Cell adhesion and extracellular matrix proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载